Strengths and limitations
This review encompasses current literature by a sys tematic review and organises the evidence in human and animal studies separately. The key cytokines and their dominant role in the development of tendon disease could not be deter mined due to the small number and heterogeneity of samples and models.
introduction
Tendon disease is increasingly common and comprises a third of all musculoskeletal complaints. 1 The tendon tissue of earlystage disease, commonly referred to as tendinopathy, is characterised by the development of fibrosis: disoriented collagen fibres; altered composi tion of extracellular matrix (ECM) proteins; formation of new vessels; and rounding of tendon cells. 2 The accu mulation of fibrotic tissue predisposes to injury and tendon tear. 3, 4 The aetiology of tendon disease is acknowledged to be multifactorial, with overuse, trauma, ageing, and genetic predisposition as notable factors; 5 however, the involvement of inflammation has long been debated. 6 Today, emerging evidence indi cates a strong inflammatory component to the patho genesis of tendon disease, with inflammatory cells and cytokines as important regulators of the tendon ECM. 7, 8 Cytokines such as interleukins (Il), tumour necrosis fac tor alpha (TNFα) and interferon gamma (IFNγ), along side growth factors such as transforming growth factor beta (TGFβ) and plateletderived growth factor, are released from tendon stromal and immunoregulatory cells in response to tissue injury, mechanical stress, and malfunction. 3, 9, 10 They alter the cellular phenotype of the local cells and the persistence of the cellular change by chronic inflammation results in the production of excessive and inappropriate matrix proteins and fibro sis. 10 Similar responses have been widely studied in fibrotic diseases in organs such as the liver, kidney, and lung. 11 The aim of this study was to systematically review the key cytokines that are involved in the development of tendon disease with a focus on fibrosis. The first objec tive was to investigate the gene and protein expression of cytokines in diseased tendons along the development of tendinopathy to tear, in comparison with that of healthy tendon. The second objective was to investigate how exercise affects the expression of these cytokines in tendon tissues. we also reviewed how tendon cells respond to these cytokines in the expression of ECM genes and proteins. we hypothesised that the cytokines expressed would vary during the process of tendon dis ease development or injury healing, and that the ten don cells from normal tissue, early disease, late disease, and healing would have differential responses to these cytokines.
Materials and Methods
This systematic review was designed, undertaken, and reported based on the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) state ment. Scientific literature was obtained using the MEDlINE (U.S. National library of Medicine, Bethesda, Maryland) electronic database using the term "tendon AND cytokine" in March 2017.
The studies were included if they reported the expres sion of Ils, TNFα, and IFNγ as these were found to be the cytokines that were consistently considered through the preliminary screening. The cytokines of the TGFβ super family were excluded as we have reviewed these previ ously. 12 Studies that compared the expression of the cytokines in diseased human tendon tissues and animal models of tendon injury or exercise with that of healthy control tissue were included. The tendon tissues included in the search criteria were from the midsubstance of ten don or tendontobone enthesis. Studies on muscle tendon junctions and ligament reconstruction using tendon grafts and other soft tissues (muscles, ligaments, cartilage, fat, bursa, and synovial tissues), as well as fetal, knockout animal models, animal studies of endocrine dis orders (hyperglycaemia, menopause), and ex vivo experi mental studies were excluded. The in vitro studies that investigated the effects of the cytokines on the expression of tendon ECM genes and proteins (collagens, elastin, proteoglycans, metalloproteinases (MMPs), tissue inhibi tor of metalloproteinases (TIMPs), and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)) by healthy, diseased, or injured tendon cells were also included. Review articles, protocols, commentaries, case reports, and studies that were not reported in English were excluded. There was no limitation as to the year of publication.
our search yielded 784 results. one article was identi fied by searching through references of listed articles. Following title screening, 594 abstracts were screened to determine eligibility and 57 papers met the inclusion crite ria (Fig. 1) . The papers that met the criteria are summarised in the additional files (supplementary tables i to iii). Study characteristics. The studies that compared the expression of cytokines in diseased human tendons obtained tissue samples from healthy, tendinopathic, torn, and healing tendons after surgical repair of the rotator cuff (RC), Achilles, patella, posterior tibialis, digital flexors, and extensor carpal radialis brevis. The effect of exercise was studied in the Achilles and patellar tendons. Five out of 17 studies on human tendon tissues used a gene micro or cytometric bead array to determine the cytokines of interest in diseased human tendon tissues (supplementary table i).
The animal tendon injury models were wideranging, using the Achilles, RC, or flexor digitorum (FD) tendons in rats, dogs, and rabbits, with injuries created by collagenase, crush injury, partial transection, and full transection. Depending on the study, the transected tendons were repaired surgically or left to heal sponta neously. The animal tendon exercise models used the patellar, Achilles, RC, or FD tendons of rats or rabbits. Studies on horse tendon tissues obtained clinical sam ples of FD tendinopathy and compared the expression of cytokines with that of healthy tendon tissues. There were three out of 30 animal studies that used an array to determine the cytokines involved (supplementary table ii).
The in vitro studies investigated the effects of cytokines on the expression of tendon ECM genes and proteins in healthy, disease, or injured human and animal tendons. Human tendon cells were obtained from normal or tendi nopathic tendons. The anatomy and species differed in all of the studies using animal tendon cells, which included healthy horse FD, injured mouse Achilles, and both healthy and injured rat patellar tendons (supple mentary table iii).
Study methodology and assessing the risk of bias. The quality of study methodology was assessed in all papers by referring to the modified scoring system by Dean et al 8 and Morita et al 12 in order to highlight the studies with a high risk of potential bias. The median score was 8 (inter quartile range, 7 to 9) out of 10 (supplementary table iv). Eight human tissue studies, six animal model tissue studies, and five in vitro experiment studies did not fully describe the age and gender of the included subjects. All of the included studies clearly described the control group. one study obtained the control tissue from the unaffected region of the tendinopathic tendon under confirmation by ultrasonography. There were three stud ies that sampled diseased tissues based on gross inspec tion, which may be a risk of bias. All except four studies clearly described the experimental procedures of tissue sampling and analysis, and 32 documented the validity or reliability of the methods used. Seven studies did not use quantitative measures or statistical analysis for com parison. of the 51 studies that used quantitative analysis Records after reviews, protocols, commentaries, case reports and non-English articles removed (n = 594)
Screening of paper abstracts with statistical comparison, 45 stated the statistical level of significance, but only eight checked the data for nor mal distribution. Study limitations were not addressed in 21 studies. A metaanalysis was not carried out due to the heterogeneity of the data from clinical samples and animal models.
Results
A total of 20 cytokines were implicated in the development of tendon disease, healing or in response to exercise: Il1α, Il1β, Il2, Il3, Il4, Il6, Il8, Il10, Il11, Il12, Il13, Il14, Il15, Il17, Il18, Il27, TNFα, and IFNγ were identi fied by arraybased studies (seven studies); and Il21 and Il33 were guided by literature. Il1β, Il6, Il10, and TNFα had been investigated in numerous (more than ten) hypoth esisfree and literatureguided studies (Fig. 2) . Hence, the results on these four cytokines were summarised (Table I) . Results of other cytokines are summarised in the additional files (supplementary table v). Effects of cytokines on the expression of tendon ECM genes and proteins in tendon cells have been presented for Il1β, Il6, Il10, and TNFα, similarly (Table II) . Results of other cytokines are shown in the additional files (supplementary table vi). iL-1β. In clinical samples, gene expression was decreased and protein expression increased in torn RC, but it remained unchanged in torn Achilles tendon tissues and after repair, exercise, or tendinopathy. 1317 The role of Il1β in human tendon disease or after exercise could not be concluded. In animal injury models, gene and protein expression of Il1β tended to increase at the early stages of tendon injury or healing until two weeks after the intervention. 1825 Similarly, exercise tended to increase the gene and protein expression of Il1β in the early stages. 2638 Treatment of tendon cells with Il1β showed catabolic effects such as increased expression of matrix metalloproteinase (MMPs), with a significant dif ference between cells from healthy and injured patellar tendons. 39 iL-6. Gene and protein expression of Il6 tended to be increased in RC and Achilles tendon tear patient sam ples, 4042 which continued until two weeks postsurgical repair, 16 but not in patients with Achilles, RC, or poste rior tibialis tendinopathy. 17, 4143 Increased Il6 protein expression was noted after prolonged running in healthy tendons, 44, 45 but not in tendinopathic Achilles tendons. 14 In animal injury models, gene, and protein expression of Il6 was increased from two hours to four weeks after the intervention. 18, 19, 21, 26, 46 The effect of exercise was inconsistent in animal models. 26, 27, 36, 38, 40 Il6 treatment on tendon cells did not have any effect on the expression of tendon ECM genes and proteins. 47 iL-10. The expression of Il10 was inconsistent in clinical samples 13, 14, 16, 17, 41 and animal injury models. 18, 20, 21, 46, 48, 49 No effects of exercise on the expression of Il10 were noted in either humans or animals. 26, 32, 34, 36, 38 Il10 treat ment on tendon cells did not have any effect on the expression of tendon ECM genes and proteins. 47 tNF-α. Gene and protein expression of TNFα tended not to change in clinical samples of RC and Achilles tendi nopathy and tear patients. 16, 40, 41, 50 The effect of exercise on the expression of TNFα in healthy human tendons has not been reported. In animal injury models, gene expression of TNFα was elevated from two hours to nine days and declined at two weeks after the interven tion, 19, 20, 21, 25, 51 whereas the protein expression increased after four days. The effect of exercise on the gene and protein expression of TNFα was inconclusive in animal models. 26, 31, 32, 3438 The effects of TNFα on tendon cells could not be concluded as genes of interest differed between studies. 47 Number of studies of human tendon tissues and animal tendon injury or exercise models for each cytokine. 
Rat
Rotator cuff, tendinopathy model, transection + repair → (1 wk) 60 Rotator cuff, exercise ↑ (4 wks) 40 Achilles, partial transection → (1 day) ↑ (4 days) 20 Achilles, crush → (1 day) 21 ↑ (5 days) 51 (Continued)
Discussion
This systematic review shows that Il1β, Il6, Il10, and TNFα are the most frequently investigated cytokines in the development and progression of tendon disease, during tendon healing and in response to exercise. Most studies focused on inflammatory cytokines based on pre vious literature, and only a few studies used hypothesis free approaches to define the implicated cytokines. Expression of Il1β, Il6, Il10, and TNFα differed depending on the stage of the tendon disease develop ment, injury healing, and in response to exercise: Il1β tended to increase in the early stage of tendon injury or exercise in animal models; Il6 was suggested to increase at tendon tear, after prolonged exercise in healthy human tendons, and in the early stage of tendon injury in animal models; Il10 remained unchanged in response to exer cise in both humans and animals; and TNFα tended to increase in the early stage of animal tendon injury mod els. Their functional mechanism in tendon disease devel opment or healing could not be determined due to the small number of studies. The cellular response to Il1β treatment significantly differed between injured and healthy tendon cells, but the involvement of other cytokines in tendon disease, healing, or after exercise could not be determined due to the paucity of studies or the inconsistency of the results thus far.
we were not able to identify the key cytokines through array studies alone due to the small number of studies, and due to the heterogeneity of clinical samples and ani mal models. An arbitrary number of more than ten stud ies was set to focus on the cytokines that had been investigated frequently in the literature. However, there was a wide variety of the anatomical locations of the dis eased and control tendons, diagnostic criteria of tendi nopathy, intervention, and the methods of gene or protein expression analysis in both human and animal studies. Tendons respond differently despite similar inter vention based on anatomical location, function, 53 and the content of exercises. 37 variances of the study limited the performing of a metaanalysis.
SchulzeTanzil et al 3 and Millar, Murrell, and McInnes 54 have indicated through narrative reviews that multiple cytokines such as Il1β, Il4, Il6, Il13, Il15, Il17, Il18, Il21, Il33, and TNF family members alongside TGFβ contribute to the development of tendon disease. By carrying out a systematic review, we captured all cur rent literature and organised the evidence in human and animal studies separately. This largely supported the data presented in previous narrative reviews. Animal studies have been helpful in understanding tendon healing and the effect of exercise, but only represent limited features of the pathophysiology and clinical diseases. 55 on the four most investigated cytokines suggest that the expression of cytokines in diseased human tendons and animal models does not act in the same manner. Numerous cytokines have been proposed to contrib ute to the development of tendon pathology, but there is a clear shortage of analyses on humanderived tendon tissue and cells. There is a risk of noting Il1β, Il6, Il10, and TNFα as the key cytokines in tendon disease just for their frequent investigation. More work is warranted through individual interrogation to specify the cytokines that actually play prominent roles. Dakin et al 41 indicated that advancedstage disease tendon tissues from large to massive tears have a tissue inflammation signature char acterised by the activation of signal transducer and acti vator of transcription 6, which is predominantly activated by cytokines such as Il4. Millar et al, 56, 57 through mecha nistic studies, have proposed Il33 as an alarmin that trig gers inflammation and Il17A as an inflammatory modulator regulating cytokines, which contribute to the development and progress of tendon disease. There is clearly a strong inflammatory component in the develop ment of tendon disease, with cytokines, which thus far have not been investigated frequently, potentially play ing a substantial role. In the case of rheumatoid arthritis, TNFα unexpectedly turned out to be the master regula tor of the proinflammatory cytokines contributing to the disease. 58 Moreover, it may also be important to consider interplay of numerous inflammatory processes with regard to different cell types, receptors, and biological and physical environments, and not just to focus on a limited number of molecules.
The cellular response of tendon cells to cytokines in the expression of tendon ECM genes differed depending on cell phenotype. A study by Tohyama et al 39 suggested that infiltrating fibroblasts show significantly decreased expression of an ECM gene (MMP13) in response to Il1β treatment when compared with the response of healthy tendon cells, and this comes in line with the studies by Dakin et al 41, 59 reporting that diseased tendon stromal cells may be primed for inflammation. Although the directions of the stimulatory or inhibitory effect of Il1β in the gene and protein expression of collagens and MMPs were similar, it should be noted that the magnitude of the change may differ in cells isolated from diseased or heal ing tissues in comparison with healthy cells. 59 Currently, only a few studies have focused on the mechanisms of action of the cytokines in cells derived from tissues of dif ferent phenotypes.
Determining both the temporal expression of cytokines during tendon disease progression and the mechanism of interaction of tendon cells with focus on cell pheno type is essential in order to improve our understanding of tendon disease pathophysiology and tendon healing. A systematic approach using welldefined clinical speci mens to identify the cytokines that play a prominent role in the development of tendon disease is warranted. Further mechanistic studies on cytokine biology based on context of expression and surrounding inflammatory milieu should conduce identification of fundamental therapies to improve disease management through enhancing the quality of tissue repair or slowing disease progression.
Supplementary material
Tables and figures showing the main characteristics of the papers included, results of assessment of study methodology quality, and summarised data of the expression of other cytokines in tendon tissues are avail able alongside the online version of this article at www. bjr.boneandjoint.org
